Searched for
METROPOLIS IPO
Hospital expansion cycle to keep margins rangebound, but 18 per cent revenue growth trend likely to sustain: Kotak SecuritiesIndian hospitals are set for strong revenue growth. Brokerage firm Kotak Securities predicts double-digit gains. EBITDA margins are expecte...- Diagnostic chains eye IPO route to raise fundsThe euphoria is aided by a massive spike in the share prices of already listed entities such as Metropolis Healthcare, Dr Lal Pathlabs, Med...
- IRCTC High: Sluggishness in the IPO market is unlikely to end soonIn its blockbuster market debut, IRCTC's stock closed 127.69% higher than its issue price on BSE.
- Six of 8 IPOs of 2019 see dream run in a weak market, now face acid testThe IPO market has been going through a rather dry spell this year.
- China’s Fosun International group in talks to acquire Medall HealthcareUS firm Constellation Alpha had earlier agreed to buy the Indian diagnostic chain, but deal fell through.
- Metropolis Healthcare gains 9% on market debutThe Rs 1,204 crore IPO, which was sold between April 3 to April 5, was subscribed 5.83 times.
- Metropolis IPO gets oversubscribed 5.8xThe quota for qualified institutional buyers (QIBs) was over subscribed 8.8 times.
- Metropolis Healthcare IPO sails through on Day 3, sees good QIB demandThe IPO received bids for 89,98,678 shares against the total issue size of 76,61,802 units.
- Metropolis Healthcare IPO subscribed 47% on Day 2The IPO received bids for 35,73,400 shares against the total issue size of 76,61,802 units.
- Metropolis Healthcare IPO subscribed 9% on Day 1The issue saw bids for 6,68,593 shares till 4.25 pm against the total issue size of 76,61,802 units.
- A wide array of tests makes Metropolis special: Ameera ShahIts Rs 1,204-crore initial public offer (IPO) opened for subscription on Wednesday.
- Metropolis Healthcare IPO kicks off; should you subscribe?The price band for the IPO has been fixed in the range of Rs 877-880 per share.
- Metropolis Healthcare raises Rs 530 crore from anchor investorsThe price band has been fixed in the range of Rs 877-880 per share.
- Metropolis: Tests OK, wait for listing to get clearer prognosisIn a highly fragmented, competitive, regional market, Metropolis is an organised national player.
- Inventia, Metropolis Healthcare, Xelpmoc Design get Sebi nod for IPOTe total companies getting clearance from the Sebi to launch IPO has reached 73 this year.
- Metropolis Healthcare files IPO papers with SebiShares of the company are proposed to be listed on BSE and NSE.
- Metropolis Health to file DRHP to raise Rs 2,000 crThe diagnostic market in India is about $8 bn, and growing at a CAGR of 12 per cent.
- Metropolis acquires Sanjeevani Pathology Labs in an all-cash transactionMetropolis has adopted a string of pearls strategy by either partnering or acquiring smaller brands in newer markets.
- Super Religare plans to mop up Rs 200 crDiagnostic chain Super Religare Laboratories (formerly SRL Ranbaxy) is reviving plans to dilute 15-20% stake to raise Rs 200 crore through ...
- Oberoi Constructions plans IPO, to raise Rs 100 croreReal estate firm, Oberoi Constructions, plans to raise Rs 100 crore through an initial public offer (IPO) by March next year.
Load More
